Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Five insights from the Global Burden of Disease Study 2019
Univ Roma La Sapienza, Dept Jurid & Econ Studies, Rome, Italy.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Chemistry.ORCID iD: 0000-0003-3161-0402
Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA.
Number of Authors: 15982020 (English)In: The Lancet, ISSN 0140-6736, E-ISSN 1474-547X, Vol. 396, no 10258, p. 1135-1159Article in journal, Editorial material (Other academic) Published
Abstract [en]

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3.5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.

Place, publisher, year, edition, pages
2020. Vol. 396, no 10258, p. 1135-1159
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:uu:diva-424769DOI: 10.1016/S0140-6736(20)31404-5ISI: 000579154000005PubMedID: 33069324OAI: oai:DiVA.org:uu-424769DiVA, id: diva2:1499570
Funder
Swedish Research Council, 2019-01059Danish National Research Foundation
Note

For complete list of authors see http://dx.doi.org/10.1016/S0140-6736(20)31404-5

Available from: 2020-11-09 Created: 2020-11-09 Last updated: 2020-11-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Larsson, Anders

Search in DiVA

By author/editor
Larsson, Anders
By organisation
Clinical Chemistry
In the same journal
The Lancet
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 113 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf